InBody Co.,Ltd
041830.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
153
Cost of Revenue
35
Gross Profit
119
Gross Margin
77.4%
Operating Income
28
Operating Margin
18.0%
Net Income
25
Net Margin
16.2%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
38
EBITDA Margin
25.1%
2023
12/31/2023
Revenue
128
Cost of Revenue
29
Gross Profit
99
Gross Margin
77.4%
Operating Income
33
Operating Margin
26.1%
Net Income
28
Net Margin
21.6%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
37
EBITDA Margin
28.7%
2022
12/31/2022
Revenue
120
Cost of Revenue
32
Gross Profit
88
Gross Margin
73.2%
Operating Income
31
Operating Margin
25.4%
Net Income
25
Net Margin
21.1%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
36
EBITDA Margin
30.0%
2021
12/31/2021
Revenue
103
Cost of Revenue
30
Gross Profit
73
Gross Margin
71.0%
Operating Income
27
Operating Margin
26.0%
Net Income
26
Net Margin
24.7%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
33
EBITDA Margin
31.8%
2020
12/31/2020
Revenue
80
Cost of Revenue
25
Gross Profit
55
Gross Margin
69.0%
Operating Income
14
Operating Margin
17.8%
Net Income
13
Net Margin
16.4%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
19
EBITDA Margin
23.6%